FDA authorizes Pfizer Covid booster dose for kids ages 5 to 11 years old

Posted on AllSides May 17th, 2022
From The Center
coronavirus, booster shots, FDA, Pfizer, Children
Hannah Beier | Reuters

The Food and Drug Administration on Tuesday authorized a Pfizer booster dose for children ages 5 through 11 years old at least five months after they complete their two-dose primary series.

Dr. Peter Marks, head of the FDA division responsible for vaccines, said data increasingly shows that the protection provided by two shots wanes off over time. The FDA determined that a third shot can help boost protection for children in this age group and the benefits outweigh the risks, Marks said.

The FDA decided to authorize a third shot...

Read full story
Some content from this outlet may be limited or behind a paywall.


AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
See full bias rating for CNBC
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right